17-Hydroxyprogesterone
규격
68-96-2CAS 번호
200-699-4EC 번호
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-oneIUPAC 명칭
C21H30O3화학식
330.5 g/mol분자량
hydroxyprogesterone; 68-96-2; 17ALPHA-HYDROXYPROGESTERONE; 17-Hydroxyprogesterone; Prodix; Prodox; Gestageno gador; 17-alpha-Hydroxyprogesterone; 17-Hydroxypregn-4-ene-3,20-dione; Gestageno; Hidroxiprogesterona; Hydroxyprogesteronum; 17alpha-Hydroxy-4-pregnene-3,20-dione; 17-OH Progesterone; delta(4)-Pregnene-17alpha-ol-3,20-dione; 17alpha-Hydroxy-progesterone; Pregn-4-ene-3,20-dione-17-ol; Idrossiprogesterone; alpha Hydroxy progesterone; DTXSID6040747; 17OHP; 17-Hydroxypregn-4-en-3,20-dione; (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one; CHEBI:17252; NSC-15468; 21807M87J2; DTXCID4020747; U-3096; 17 Hydroxyprogesterone; 17 alpha Hydroxyprogesterone; 17 alpha-Hydroxyprogesterone; (1S,2R,10R,11S,14R,15S)-14-acetyl-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-6-en-5-one; (1S,2R,10R,11S,14R,15S)-14-acetyl-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthren-3-one; RefChem:55376; 17-Hydroxyprogesterone, (17 alpha)-; (1S,2R,10R,11S,14R,15S)-14-acetyl-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one; 200-699-4; 17a-Hydroxyprogesterone; Pregn-4-ene-3,20-dione, 17-hydroxy-; 17|A-Hydroxyprogesterone; Setaderm; Oxiprogesteronum; Idrossiprogesterone [DCIT]; Hydroxyprogesteronum [INN-Latin]; Hidroxiprogesterona [INN-Spanish]; MFCD00003659; HSDB 3343; 17.alpha.-Hydroxyprogesterone; 4-Pregnen-17a-ol-3,20-dione; 17?-Hydroxyprogesterone; 17a-hydroxy progesterone; MLS000028453; MLS001076300; U 3096; 4-Pregnen-17alpha-ol-3,20-dione; Delta4-Pregnen-17alpha-ol-3,20-dione; NCGC00093949-03; alpha-17Hydroxypregn-4-ene-3,20-dione; SMR000058349; Hydroxyprogesterone (INN); (9beta)-17-Hydroxypregn-4-Ene-3,20-Dione; HYDROXYPROGESTERONE [INN]; CAS-68-96-2; (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; Hydroxyprogesterone [INN:BAN]; 17Alpha-hydroxy progesterone; EINECS 200-699-4; NSC 15468; 17alpha hydroxyprogesterone; BRN 2062088; UNII-21807M87J2; 3QZ; Pregn-4-ene-3,20-dione, 17-hydroxy-, (17a)-; 17-Hydroxyprogeoterone; 17-hydroxy-progesterone; 17-a-Hydroxyprogesterone; Opera_ID_1812; 17|_-Hydroxyprogesterone; 17?-Hydroxy Progesterone; bmse000472; bmse000598; Epitope ID:152220; 17|A-Hydroxy Progesterone; SCHEMBL8068; CHEMBL1062; BIDD:PXR0103; Lopac0_000565; 17.alpha.-Hydoxyprogesterone; 4-08-00-02189 (Beilstein Handbook Reference); MLS002695950; 17-alpha-hydroxy progesterone; 17-OHP; GTPL5104; orb1224234; orb1308651; orb3139113; Progesterone, 17alpha-hydroxy-; Pregn-4-ene-3,20-dione, 17-hydroxy-, (17.alpha.)-; HY-B0891R; Pregn-4-ene-3, 17-hydroxy-; 17-Hydroxyprogesterone(Standard); DTXSID00859075; HYDROXYPROGESTERONE [HSDB]; MSK8516; GLXC-08121; HMS2090M08; HMS2234J04; HMS3261B12; HYDROXYPROGESTERONE [VANDF]; D4-Pregnen-17a-ol-3,20-dione; HY-B0891; NSC15468; Pregn-4-en-17a-ol-3,20-dione; HYDROXYPROGESTERONE [WHO-DD]; Tox21_111233; Tox21_301530; Tox21_500565; 17|A-Hydroxyprogesterone (Standard); BDBM50423511; LMST02030161; MSK8516-100A; 17alpha-Hydroxyprogesterone, >=95%; 17-hydroxy-pregn-4-ene-3,20-dione; 17a-Hydroxypregn-4-ene-3,20-dione; AKOS015955623; MSK8516-1000A; Tox21_111233_1; CCG-204655; CS-4354; DB14570; EBC-380086; FD12004; FH24103; KS-5312; LP00565; SDCCGSBI-0050548.P002; 4-Pregnen-17.alpha.-ol-3,20-dione; NCGC00093949-04; NCGC00093949-05; NCGC00093949-08; NCGC00255425-01; NCGC00261250-01; (1R,3aS,3bR,9aR,9bS,11aS)-1-acetyl-1-hydroxy-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; SY033647; 17| cent-Hydroxyprogesterone (Standard); 17alpha-hydroxy-pregn-4-ene-3,20-dione; 17.ALPHA.-HYDROXYPROGESTERONE [MI]; 17.alpha.-Hydroxypregna-4-ene-3,20-dione; EU-0100565; H1250; NS00115894; ST50411345; C01176; D08052; H 5752; 17-Hydroxypregn-4-ene-3,20-dione, (+/-)-; AB00490003-08; 17-Alpha-Hydroxyprogesterone, 1mg/ml in Methanol; F229937; Q175901; 17.ALPHA.-HYDROXYPREGN-4-ENE-3,20-DIONE; 17-Hydroxypregn-4-ene-3,20-dione-, (17.alpha.)-; 7A45BEF6-ADD0-4B3E-A014-2DE930D3B67B; 17alpha-Hydroxyprogesterone Solution in Acetonitrile, 100ug/mL; 17alpha-Hydroxyprogesterone, VETRANAL(TM), analytical standard; 17alpha-Hydroxyprogesterone Solution in Acetonitrile, 1000ug/mL; 17|A-Hydroxy-4-pregnene-3,20-dione; 4-Pregnen-17|A-ol-3,20-dione; (1S,11S,15S,2R,10R,14R)-14-acetyl-14-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7 .0.0<2,7>.0<11,15>]heptadec-6-ene; (8R,10R,13S,17R)-17-Acetyl-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one; 110850-01-6; 17-hydroxyprogesterone; 17alpha-Hydroxy-4-pregnene-3,20-dione; 17alpha-Hydroxy-progesterone; 17alpha-Hydroxyprogesterone; Pregn-4-ene-3,20-dione-17-ol; hydroxyprogesterone동의어
